UnitedHealth Group Incorporated (NYSE:UNH) Holdings Raised by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.8% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 345,917 shares of the healthcare conglomerate's stock after acquiring an additional 18,849 shares during the period. UnitedHealth Group comprises 1.8% of Sumitomo Mitsui DS Asset Management Company Ltd's portfolio, making the stock its 6th biggest position. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in UnitedHealth Group were worth $181,174,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Norges Bank acquired a new stake in UnitedHealth Group in the 4th quarter worth about $6,375,744,000. GAMMA Investing LLC boosted its stake in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $1,914,740,000. Amundi grew its position in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after buying an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. JPMorgan Chase & Co. raised their price objective on shares of UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research report on Friday, June 20th. Raymond James Financial lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Finally, Robert W. Baird lowered UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective on the stock. in a research note on Wednesday, June 11th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

UnitedHealth Group Trading Up 0.4%

UNH traded up $1.13 during trading on Thursday, reaching $308.69. The company had a trading volume of 6,148,637 shares, compared to its average volume of 7,522,605. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The stock has a market cap of $280.03 billion, a P/E ratio of 12.93, a PEG ratio of 1.55 and a beta of 0.45. The business has a 50 day simple moving average of $329.50 and a 200-day simple moving average of $450.21.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period last year, the company earned $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group's payout ratio is 37.02%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Stephen J. Hemsley acquired 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.